EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 23 March 2023

News

New European legislation designed to protect patients is delaying clinical trials for thousands...
20 March 2023

The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the... Read more

EU long-term competitiveness strategy has to apply to the EU Pharma legislation
21 March 2023

We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver... Read more

Blogs

Why pull incentives are key to catalysing private investment into antibiotics
21 March 2023

The advent of antibiotics was one of the fundamental drivers of the shift in health care that has dramatically increased... Read more

Events

Strengthening European health systems
24 April 2023 (Online)

How to invest in innovation while driving efficiencies. Read more

The Estimands Academy for Trial Teams: Bringing estimands to life through case studies
30 March 2023 (Online)

Webinar 4 - Proposing Estimands from Different Perspectives: Patient, Clinician, Regulator, Health Technology Assessor... Read more

We published

Regulatory Road to Innovation Experts' Insights
22 March 2023 (Publications)

How can we work together to create a world-class 21st century regulatory framework to deliver safer, better medicines... Read more

What we are reading

EU pharma reform delayed again due to Commission’s busy agenda
On 22 March 2023 (EurActiv)

The Commission’s initiative, which will aim at ensuring a future-proof and crisis-resistant medicines regulatory... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu